• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2015 年度 実施状況報告書

Runx-mediated regulation of chemokine CCL5 for lung diseases

研究課題

研究課題/領域番号 15K08535
研究機関国立研究開発法人理化学研究所

研究代表者

SEO WOOSEOK  国立研究開発法人理化学研究所, 統合生命医科学研究センター, 国際特別研究員 (40574116)

研究期間 (年度) 2015-10-21 – 2018-03-31
キーワードアレルギー / 免疫関連疾患
研究実績の概要

The first aim of this project was to generate a knockout mouse by Crispr/Cas9 technology in which a binding region of Runx transcription factor on CCL5 locus is removed. According to the proposal, I have successfully generated the knockout mouse and in the process of the initial examination of the mouse line. Preliminary data by flow cytometry analysis show that CCL5 expression is almost completely eliminated in the absence of the Runx-binding region indicating that this novel DNA region is crucial for CCL5 expression. To gain further insight, I have generated a BAC (Bacterial Artificial Chromosome) transgenic construct in which Runx-binding sequences on this Runx-binding region on CCL5 are mutated. This will be injected into mouse embryo to generated transgenic mouse line as we proposed.

現在までの達成度 (区分)
現在までの達成度 (区分)

2: おおむね順調に進展している

理由

To propose and prove a novel regulatory pathway of CCL5 expression by Runx transcription factor, my experimental plan was to generate two powerful tools using mouse genetics. The first tool was to construct a mouse line in which Runx-binding to CCL5 locus is abolished. This mouse line was successfully made and its analysis has been generating interesting results. The second tool was to create a BAC transgenic mouse line in which Runx-binding consensus sequences on CCL5 locus are specifically mutated to abolish the influences of Runx on CCL5 expression without removing a chunk of DNA region. This BAC construct is already made and will be submitted to generate the transgenic mouse line. Therefore, the current progress of the project is slightly ahead of its schedule.

今後の研究の推進方策

I expect to have this new BAC transgenic mouse line within this fiscal year. While waiting for the successful generation of the mouse line, I will continue to analyze the knockout mouse I generated in the last fiscal year to carefully examine the interesting phenotype. To further prove that this region plays a crucial function in controlling CCL5 expression, I am going to perform ChIP-seq (chromatin immunoprecipitation sequencing) to visualize genomic binding of Runx transcription factor in peripheral CD4+ T help cells and CD8+ T cytotoxic cells. This is quite important since it have been shown that this Runx-binding region on CCL5 has a SNP which is associated with severe liver fibrosis.

次年度使用額が生じた理由

27年10月に追加採択されたので、次年度使用額が生ました。

次年度使用額の使用計画

27年度に製作すろことだったトランスジェニックマウスを28年度に製作。
研究費使用期間が3年から2年半に少し短くなったが、進捗状況は順調。

  • 研究成果

    (3件)

すべて 2016 2015

すべて 雑誌論文 (1件) (うち国際共著 1件、 査読あり 1件、 謝辞記載あり 1件) 学会発表 (2件) (うち招待講演 1件)

  • [雑誌論文] Transcriptional regulation of early T-cell development in the thymus2016

    • 著者名/発表者名
      Seo W. and Taniuchi I.
    • 雑誌名

      European Journal of Immunology

      巻: 46 ページ: 531-538

    • DOI

      10.1002/eji.201545821

    • 査読あり / 国際共著 / 謝辞記載あり
  • [学会発表] Control of thymocyte fate decision by local chromatin structure2015

    • 著者名/発表者名
      Wooseok Seo
    • 学会等名
      2015 Annual Meeting of Molecular Biology Society of Japan
    • 発表場所
      Kobe International Convention Center, Kobe, Hyogo
    • 年月日
      2015-12-04
    • 招待講演
  • [学会発表] Repression of CCL5 by Runx/CBFβ is essential to prevent lung infiltration2015

    • 著者名/発表者名
      Wooseok Seo
    • 学会等名
      2015 Annual Meeting of Japanese Society of Immunlogy
    • 発表場所
      Sapporo Convention Center, Sapporo, Hokkaido
    • 年月日
      2015-11-18

URL: 

公開日: 2017-01-06  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi